3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
405
Glioma
261
Glioblastoma
204
Central Nervous System Neoplasms
92
Neoplasms
87
Neuroblastoma
82
Astrocytoma
72
Neurofibromatosis 1
55
Breast Neoplasms
52
Meningioma
51
Lung Neoplasms
42
Oligodendroglioma
39
Head and Neck Neoplasms
35
Medulloblastoma
33
Spinal Cord Neoplasms
30
Sarcoma
30
Leukemia
30
Paraganglioma
29
Pheochromocytoma
28
Lymphoma
28
Carcinoma, Non-Small-Cell Lung
27
Prostatic Neoplasms
24
Neuroma, Acoustic
24
Ependymoma
24
Melanoma
22
Recurrence
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Ovarian Neoplasms
20
Neoplasm Metastasis
19
Lymphoma, Non-Hodgkin
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lymphangioleiomyomatosis
×
CNS
×
Clear all
NCT02654340
2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
20 enrolled